We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Editorial Comment from Dr Wu to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer.
- Authors
Wu, Boyang Jason
- Abstract
The article presents author's views regarding the use of sulfoquinovosylacylpropanediol as a potent radiosensitizer in treatment of prostate cancer. Topics discussed include combines use of sulfoquinovosylacylpropanediol (SQAP) and X-ray irradiation for treatment of prostate cancer, radiosensitivity of colon cancer cells and increasing popularity of use of radiotherapy in prostate cancer monotherapy.
- Subjects
PROSTATE cancer treatment; PROSTATE cancer patients; RADIATION-sensitizing agents; IRRADIATION; COLON cancer
- Publication
International Journal of Urology, 2015, Vol 22, Issue 6, p596
- ISSN
0919-8172
- Publication type
Editorial
- DOI
10.1111/iju.12774